HI
SCMP

HBK Investments’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

HBK Investments’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-77,600
Closed -$1.34M – 1209
2015
Q4 		$1.34M Sell
77,600
-79,800
-51% -$1.43M 0.01% 501
2015
Q3 		$3.13M Buy
+157,400
New +$3.61M 0.03% 326

Other funds holding SCMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

HBK Investments's SCMP Position: Q1 2016 in Review

HBK Investments sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2016, closing a stake of 77,600 shares — an estimated $1.34M sold.

HBK Investments first reported a position in SCMP in Q3 2015 and held it in 2 quarters. The position peaked at $3.13M in Q3 2015. 134 funds tracked by Wall St. Rank hold SCMP as of Q1 2016.

  • HBK Investments reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • HBK Investments sold 77,600 Sucampo Pharmaceuticals, Inc. shares in Q1 2016, an estimated $1.34M.
  • HBK Investments first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 2 quarters.
  • HBK Investments's Sucampo Pharmaceuticals, Inc. position peaked at $3.13M in Q3 2015.
  • 134 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2016.

Based on HBK Investments's 13F filing for Q1 2016, filed 13 May 2016.